The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. [electronic resource]
Producer: 20050804Description: 374-82 p. digitalISSN:- 1088-0224
- Adult
- Aged
- Anti-Allergic Agents -- administration & dosage
- California
- Cost-Benefit Analysis
- Drug Prescriptions
- Drug Utilization Review -- statistics & numerical data
- Female
- Humans
- Insurance, Pharmaceutical Services -- economics
- Loratadine -- economics
- Male
- Middle Aged
- Nonprescription Drugs
- Rhinitis, Allergic, Perennial -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.